Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.83 is 57% above its 5-year average of -1.94, near the high end of its 5-year range (-4.24–-0.83).
31.12% above its 12-month average of -1.21.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.83
EARNINGS PER SHARE (EPS) AVG TTM
-1.21
EARNINGS PER SHARE (EPS) AVG 3Y
-1.36
EARNINGS PER SHARE (EPS) AVG 5Y
-1.94
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+31.12%
CURRENT VS 3Y AVG
+38.86%
CURRENT VS 5Y AVG
+57.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Climb Bio, Inc.
Market Cap
$632.76M
Earnings Per Share (EPS)
-0.83
TTM Avg
-1.21
3Y Avg
-1.36
5Y Avg
-1.94
Market Cap
$637.59M
Earnings Per Share (EPS)
-2.82
TTM Avg
-1.69
3Y Avg
-1.06
5Y Avg
3.72
Market Cap
$642.31M
Earnings Per Share (EPS)
-0.88
TTM Avg
-0.85
3Y Avg
-1.91
5Y Avg
-1.52
Market Cap
$643.37M
Earnings Per Share (EPS)
-1.78
TTM Avg
-1.75
3Y Avg
-1.85
5Y Avg
-1.69
Market Cap
$600.84M
Earnings Per Share (EPS)
0.77
TTM Avg
0.08
3Y Avg
-1.29
5Y Avg
-0.21
Market Cap
$596.36M
Earnings Per Share (EPS)
-0.58
TTM Avg
-1.12
3Y Avg
-1.21
5Y Avg
-1.27
Market Cap
$675.41M
Earnings Per Share (EPS)
-2.72
TTM Avg
-2.70
3Y Avg
-2.77
5Y Avg
-2.61
Market Cap
$587.93M
Earnings Per Share (EPS)
-1.68
TTM Avg
-1.67
3Y Avg
-1.05
5Y Avg
-1.14
Market Cap
$579.88M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.57
3Y Avg
-1.57
5Y Avg
-1.57
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Climb Bio, Inc. (CLYM) | $632.76M | -0.83 | -1.21 | -1.36 | -1.94 |
| Fulgent Genetics, Inc. (FLGT)vs › | $637.59M | -2.82 | -1.69 | -1.06 | 3.72 |
| AngioDynamics, Inc. (ANGO)vs › | $642.31M | -0.88 | -0.85 | -1.91 | -1.52 |
| Aura Biosciences, Inc. (AURA)vs › | $643.37M | -1.78 | -1.75 | -1.85 | -1.69 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.84M | 0.77 | 0.08 | -1.29 | -0.21 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | -0.58 | -1.12 | -1.21 | -1.27 |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $675.41M | -2.72 | -2.70 | -2.77 | -2.61 |
| OrthoPediatrics Corp. (KIDS)vs › | $587.93M | -1.68 | -1.67 | -1.05 | -1.14 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | N/A | -1.57 | -1.57 | -1.57 |
| Annexon, Inc. (ANNX)vs › | $688.14M | -1.16 | -1.18 | -1.68 | -2.29 |
Trailing EPS (TTM)
$-0.83
Forward EPS (Est.)
$-0.79
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.88 |
| 2024-12-31 | -1.53 |
| 2023-12-31 | -1.30 |
| 2022-12-31 | -1.72 |
| 2021-12-31 | -4.24 |
| 2020-12-31 | -1.97 |
| 2019-12-31 | -0.56 |
